0.2590SEK-1.33%Mkt Cap: 302.24M SEKP/E: —Last update: 2026-05-13
Acarix AB (publ), a medical device company, develops solutions for rapid AI-based coronary artery disease rule-out. The company offers CADScor System, a point-of-care diagnostic aid that uses sensitive acoustics and adva…
Industry Peers
Medical Devicesloading…
Indicators:|
Key Statistics
Valuation
P/E (Trailing)—
P/E (Forward)—
PEG—
P/B7.86
P/S41.06
EV/EBITDA-6.04
EV/Revenue38.56
EPS (TTM)-0.04
EPS (Forward)0.00
Cash Flow & Leverage
FCF Yield-11.05%
FCF Margin-453.90%
Operating CF-37.28M SEK
CapEx (TTM)757.00K SEK
Net Debt/EBITDA0.39
Net Debt-18.42M SEK
Technical
SMA 500.2791 (-7.2%)
SMA 2000.2888 (-10.3%)
Beta-0.26
S&P 52W Chg24.23%
Avg Vol (30d)1.23M
Avg Vol (10d)1.82M
Technical Indicators
RSI (14)38.1
MACD-0.0065
MACD Signal-0.0042
MACD Hist.-0.0023
BB Upper0.3081 SEK
BB Middle0.2777 SEK
BB Lower0.2474 SEK
BB Width21.87%
ATR (14)0.0143 SEK
Vol Ratio (20d)0.73x
52W Range
0.191424% of range0.4710
52W High0.4710 SEK
52W Low0.1914 SEK
Profitability
Gross Margin84.74%
EBITDA Margin0.00%
Profit Margin-653.32%
Oper. Margin-558.43%
ROE-125.99%
ROA-99.51%
Revenue Growth26.00%
Earnings Growth—
Balance Sheet
Debt/Equity—
Current Ratio4.08
Quick Ratio3.36
Book Value/Sh0.0330 SEK
Cash/Share0.0160 SEK
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 SEK
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Ownership
Shares Out.1.16B
Float1.03B
Insiders15.26%
Institutions1.28%
Analyst Consensus
Rating—
Target (Mean)0.4000 SEK
Target Range0.4000 SEK – 0.4000 SEK
# Analysts1
Company
Market Cap302.24M SEK
Enterprise Value283.82M SEK
Revenue (TTM)7.36M SEK
Gross Profit6.24M SEK
Net Income (TTM)-48.09M SEK
Revenue/Share0.0070 SEK
Fiscal Year EndDec 2025
MR QuarterDec 2025
Employees8
Last Price0.2590 SEK
CountrySE
SectorHealthcare
IndustryMedical Devices
ISIN—